These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28807065)

  • 1. Possible role of Dickkopf-1 protein in the pathogenesis of tympanosclerosis in a rat model.
    Zhang Y; Wang S; Zheng Y; Liu A
    J Laryngol Otol; 2017 Oct; 131(10):860-865. PubMed ID: 28807065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Possible Role of Sclerostin in the Pathogenesis of Tympanosclerosis.
    Huang Y; Wang X; Wu F; Lu Y; Liang G; Liu A
    Audiol Neurootol; 2021; 26(2):102-110. PubMed ID: 33508832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical investigation of inducible nitric oxide synthase, osteopontin, and calcium-sensing receptor in a myringosclerosis/tympanosclerosis model.
    Kucuktag Z; Satar B; Yetiser S; Hidir Y; Gunhan O
    Otol Neurotol; 2014 Jan; 35(1):e15-23. PubMed ID: 24136309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of TGF-β1 and MMP-9 in a guinea pig model of tympanosclerosis: possible role in the pathogenesis of this disorder.
    Guo W; Bai X; Han Y; Xu L; Liu W; Zhang G; Li J; Fan Z; Wang H
    Laryngoscope; 2012 Sep; 122(9):2037-42. PubMed ID: 22777961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile of collagen types, osteopontin in the tympanic membrane of patients with tympanosclerosis.
    Sakowicz-Burkiewicz M; Kuczkowski J; Przybyła T; Grdeń M; Starzyńska A; Pawełczyk T
    Adv Clin Exp Med; 2017 Sep; 26(6):961-966. PubMed ID: 29068597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TGF-β1-mediated epithelial-mesenchymal transition in the pathogenesis of tympanosclerosis.
    Qiu J; Wang Y; Guo W; Xu L; Mou Y; Cui L; Han F; Sun Y
    Exp Ther Med; 2021 Jan; 21(1):6. PubMed ID: 33235615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of calcium channel blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.
    Selcuk A; Akdogan O; Ozcan I; Giray SG; Dere H; Ozogul C
    Laryngoscope; 2008 Apr; 118(4):697-705. PubMed ID: 18176349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin e treatment.
    Polat S; Oztürk O; Uneri C; Yüksel M; Haklar G; Bozkurt S; Küllü S
    Laryngoscope; 2004 Apr; 114(4):720-5. PubMed ID: 15064630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of topical doxycycline in the prevention of experimental tympanosclerosis.
    Ozcan I; Selcuk A; Ozcan KM; Akdogan O; Giray SG; Dere H; Ozogul C
    Laryngoscope; 2008 Jun; 118(6):1051-6. PubMed ID: 18388770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible inflammatory mediators in tympanosclerosis development.
    Forséni Flodin M; Hultcrantz M
    Int J Pediatr Otorhinolaryngol; 2002 Apr; 63(2):149-54. PubMed ID: 11955606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of reactive oxygen species in rat tympanic membranes after incisional versus radiofrequency myringotomy.
    Sakalli E; Baylancicek S; Yuksel M; Erdurak SC; Dadas B
    Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):792-5. PubMed ID: 23478016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does exogenous nitric oxide influence tympanosclerosis? An experimental study.
    Atmaca S; Erol Y; Coban AY; Yildiz L; Cengel S; Koyuncu M
    Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1845-8. PubMed ID: 18945497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
    Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
    Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tympanosclerosis: can predicting factors be identified?
    Forséni M; Eriksson A; Bagger-Sjöbäck D; Nilsson J; Hultcrantz M
    Am J Otol; 1997 May; 18(3):298-303. PubMed ID: 9149821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat.
    Spratley JE; Hellström SO; Mattsson CK; Pais-Clemente M
    Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):585-91. PubMed ID: 11407852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane.
    Ozcan C; Görür K; Cinel L; Talas DU; Unal M; Cinel I
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):179-84. PubMed ID: 11997152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of Tumor Necrosis Factor alpha gene expression profile in selected structures of middle ear in patients with tympanosclerosis].
    Mionskowski T; Kuczkowski J; Sakowicz-Burkiewicz M
    Otolaryngol Pol; 2012 Sep; 66(4 Suppl):20-4. PubMed ID: 23164102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does systemic clarithromycin therapy have an inhibitory effect on tympanosclerosis? An experimental animal study.
    Genc G; Koyuncu M; Kutlar G; Guvenc T; Gacar A; Aksoy A; Arslan S; Kurnaz SC
    J Laryngol Otol; 2015 Feb; 129(2):136-41. PubMed ID: 25619629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis.
    Song JJ; Kwon SK; Cho CG; Park SW
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1287-91. PubMed ID: 17544518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tympanosclerosis in the rat tympanic membrane: an experimental study.
    Russell JD; Giles JJ
    Laryngoscope; 2002 Sep; 112(9):1663-6. PubMed ID: 12352683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.